How Oxandrolone Affects SHBG

Oxandrolone suppresses hepatic SHBG synthesis through first-pass metabolism. The 17-alpha-alkyl group survives first-pass deactivation and produces sustained hepatic exposure, which downregulates SHBG production at the transcriptional level.

Two mechanisms shape what shows on bloodwork:

1. Direct hepatic suppression: Oxandrolone reaches the liver at high concentration via portal circulation and acts on hepatocytes to reduce SHBG mRNA expression. The Haeusler 1996 Turner syndrome study (PMID 8636264) documented "dramatic" SHBG decrease at doses as low as 0.0625 mg/kg/day, equivalent to roughly 3 to 5 mg/day in an adult woman.
2. Free hormone amplification: Because SHBG is the primary carrier protein for sex steroids, suppression releases bound testosterone and DHT into the bioavailable pool. Total testosterone might double on cycle, but free testosterone can rise 8 to 15 fold because all of it becomes bioavailable.

The combination is what makes oxandrolone uniquely problematic for women: a "mild" total testosterone elevation looks reassuring on paper while free testosterone reaches male physiologic range or higher.

Replacement-context low doses (5 mg/day):

• SHBG drops 40 to 60 percent within 2 to 4 weeks
• Baseline 30 to 90 nmol/L falls to 12 to 30 nmol/L
• Free testosterone rises 2 to 4 fold

Standard bodybuilding doses in women (10 to 20 mg/day):

• SHBG drops 70 to 90 percent within 2 to 4 weeks
• Baseline 30 to 90 nmol/L falls below 10 nmol/L in most users
• Free testosterone rises 4 to 15 fold depending on dose and individual sensitivity

Higher female doses (>20 mg/day, not recommended):

• SHBG can drop to single digits or below assay detection limits
• Free testosterone can reach male physiologic range, with virilization risk accelerating

Timing: Onset within days, full suppression by week 2 to 4, sustained through cycle. Recovery to baseline takes 4 to 8 weeks after stopping (faster than testosterone or gonadotropin recovery).

Baseline before starting: Pull SHBG along with total testosterone, free testosterone, DHT, LH, FSH, and estradiol. SHBG baseline is the only way to interpret the on-cycle drop in context.

Week 2 to 3 (early signal): Recheck SHBG. This is the earliest warning marker. If SHBG is already below 15 at week 2, the cycle is hitting harder than expected.

Week 4 to 6 (mid-cycle): Repeat SHBG + free testosterone + total testosterone + DHT. The free T to total T ratio tells you how much of your androgen load is bioavailable.

Action thresholds:

• SHBG below 15 nmol/L: warning. Free T is rising disproportionately.
• SHBG below 10 nmol/L: stop or reduce dose. The early warning system is offline.
• Free testosterone above 130 pmol/L (about 2x female upper limit): stop regardless of SHBG.

Post-cycle: Pull SHBG at 4 and 8 weeks off-cycle to confirm recovery. Full normalization typically by week 8.

Reducing SHBG impact without stopping:

• Lower the dose: 10 mg/day produces meaningfully less SHBG suppression than 20 mg/day
• Shorten the cycle: 4 to 6 week cycles suppress less than 8 to 12 week cycles
• Avoid stacking with other 17-alpha-alkylated orals (winstrol, dianabol, anadrol) which compound SHBG suppression

The free T trap:

• Watching only total testosterone gives dangerously false reassurance because SHBG suppression amplifies free T disproportionately
• Always measure free T directly (or calculate from total T, SHBG, and albumin) when SHBG is suppressed
• Standard female reference for free T is 10 to 66 pmol/L; oxandrolone users at 10 to 20 mg/day routinely hit 80 to 200+ pmol/L

Recovery framing:

• SHBG recovery is one of the fastest markers to normalize off-cycle
• A 4 to 8 week recovery window is typical, faster than HDL (4 to 12 weeks) or HPG axis (13 to 24 weeks)
• This is good news: if you stop early enough, SHBG and free T normalize within weeks